Expression of IL-8 and ICAM-1 is dependent on c-Jun N-terminal kinase (JNK) activity [35, 36], and increased JNK activation has also been identified as critical pathological factor in the progression from steatosis to inflammation in NAFLD [37]. Here, MAPK8 is linked to metabolic dysfunction-associated steatotic liver disease.